Skip to content

A multidimensional study on the exploration of the biological rhythm between man and nature based on the intraocular pressure curve (clinical part)

A multidimensional study on the exploration of the biological rhythm between man and nature based on the intraocular pressure curve

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2022000063
Enrollment
Unknown
Registered
2022-06-29
Start date
2022-08-10
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary open angle glaucoma

Interventions

control group:control intraocular pressure
intervention group:oral Wumei pill decoction
intervention group:control intraocular pressure

Sponsors

Eye Hospital, Chinese Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Diagnosed as primary open-angle glaucoma; (2) TCM syndrome differentiation belongs to Jueyin disease Wumei Pill syndrome; (3) Age 18 to 80 years old; (4) 24h intraocular pressure fluctuation range =8mmHg; (5) The corrected visual acuity of both eyes is greater than or equal to 0.1, and there are no other eye diseases and drugs (such as ocular trauma, retinal diseases, hormones, etc.) that may cause increased intraocular pressure and other factors that may increase the error of intraocular pressure measurement (leukoplakia, proptosis, etc.) Wait); (6) Be able to understand and be willing to receive treatment in accordance with the research protocol, and be able to follow-up consultations as required; (7) Sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients who do not meet the inclusion criteria; (2) Patients with severe cardiovascular and cerebrovascular diseases, serious diseases such as liver and kidney, hematopoietic system, and mental illness; (3) Pregnant or lactating women; (4) Participating in other clinical trials; (5) Can not cooperate with this research.

Design outcomes

Primary

MeasureTime frame
24h intraocular pressure; field of view;

Secondary

MeasureTime frame
Hydrocortisone,CORT;vision;(Pittsburgh sleep quality index,PSQI;Depression Anxiety Stress Scale 21,DASS-21;raditional Chinese medicine Syndrome Scale;Athens Insomnia Scale,AIS;melatonin,MT;

Countries

China

Contacts

Public ContactLiXia ZHANG

China Academy of Chinese Medical Sciences

zhanglixia77@126.com15601005070

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026